Abbvie Inc (NYSE:ABBV)
| 142.55 Delayed Data As of Aug 16 |  +0.26 / +0.18%Today’s Change | 105.56 Today|||52-Week Range 175.91 | +5.28% Year-to-Date |
Latest ABBV News | Press Releases
| Top 5 2nd Quarter Trades of Brick & Kyle, Associates Aug 16 / GuruFocus News - Paid Partner Content | Principal Street Partners, LLC Buys 1, Sells 4 in 2nd Quarter Aug 15 / GuruFocus News - Paid Partner Content |
| Roche's (RHHBY) sBLA For Polivy Combo Accepted by FDA Aug 16 / Zacks.com - Paid Partner Content | FIRST TRUST ADVISORS LP Buys 4, Sells 1 in 2nd Quarter Aug 12 / GuruFocus News - Paid Partner Content |
| AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It Aug 16 / Zacks.com - Paid Partner Content | FRONT BARNETT ASSOCIATES LLC Buys 1, Sells 4 in 2nd Quarter Aug 12 / GuruFocus News - Paid Partner Content |
| 5 Income Stocks to Turn to When Times Are Tough Aug 16 / StockNews.com - Paid Partner Content | Want Passive Income? Try These 3 Dividend Stocks Aug 11 / StockNews.com - Paid Partner Content |
| 3 Blue-Chip Stocks That'll Help Your Portfolio Survive Aug 16 / StockNews.com - Paid Partner Content | 4 "Strong Buy" Stocks for a Fear-Driven Market Aug 10 / StockNews.com - Paid Partner Content |
Today’s Trading
| Previous close | 142.29 |
| Today’s open | 142.30 |
| Day’s range | 142.08 - 143.87 |
| Volume | 3,852,310 |
| Average volume (3 months) | 6,771,438 |
| Market cap | $252.1B |
Data as of 4:00pm ET, 08/16/2022
Growth & Valuation
| Earnings growth (last year) | +137.07% |
| Earnings growth (this year) | +9.01% |
| Earnings growth (next 5 years) | -2.24% |
| Revenue growth (last year) | +22.69% |
| P/E ratio | 20.2 |
| Price/Sales | 4.28 |
| Price/Book | 16.37 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MRKMerck | -0.03 | -0.03% |
| PFEPfizer | +0.13 | +0.26% |
| AZNAstraZeneca | -0.07 | -0.10% |
| LLYEli Lilly and Co | -3.43 | -1.09% |
Data as of 4:00pm ET, 08/16/2022
Financials
| Next reporting date | November 4, 2022 |
| EPS forecast (this quarter) | $3.60 |
| Annual revenue (last year) | $56.2B |
| Annual profit (last year) | $11.5B |
| Net profit margin | 20.41% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters North Chicago, Illinois |
Forecasts
